Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Collin MP"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Le Roux A; Department of Pharmacology-Physiology, Institut de Pharmacologie de Sherbrooke, 3001, 12e av nord, Sherbrooke, Québec J1H 5N4, Canada., Blaise É; Department of Pharmacology-Physiology, Institut de Pharmacologie de Sherbrooke, 3001, 12e av nord, Sherbrooke, Québec J1H 5N4, Canada., Boudreault PL; Department of Pharmacology-Physiology, Institut de Pharmacologie de Sherbrooke, 3001, 12e av nord, Sherbrooke, Québec J1H 5N4, Canada., Comeau C; Department of Pharmacology-Physiology, Institut de Pharmacologie de Sherbrooke, 3001, 12e av nord, Sherbrooke, Québec J1H 5N4, Canada., Doucet A; Department of Pharmacology-Physiology, Institut de Pharmacologie de Sherbrooke, 3001, 12e av nord, Sherbrooke, Québec J1H 5N4, Canada., Giarrusso M; Department of Pharmacology-Physiology, Institut de Pharmacologie de Sherbrooke, 3001, 12e av nord, Sherbrooke, Québec J1H 5N4, Canada., Collin MP; Drug Discovery, Pharmaceuticals, Bayer AG, Wuppertal D-42096, Germany., Neubauer T; Drug Discovery, Pharmaceuticals, Bayer AG, Wuppertal D-42096, Germany., Kölling F; Drug Discovery, Pharmaceuticals, Bayer AG, Wuppertal D-42096, Germany., Göller AH; Drug Discovery, Pharmaceuticals, Bayer AG, Wuppertal D-42096, Germany., Seep L; Drug Discovery, Pharmaceuticals, Bayer AG, Wuppertal D-42096, Germany., Tshitenge DT; Drug Discovery, Pharmaceuticals, Bayer AG, Wuppertal D-42096, Germany., Wittwer M; Drug Discovery, Pharmaceuticals, Bayer AG, Wuppertal D-42096, Germany., Kullmann M; Drug Discovery, Pharmaceuticals, Bayer AG, Wuppertal D-42096, Germany., Hillisch A; Drug Discovery, Pharmaceuticals, Bayer AG, Wuppertal D-42096, Germany., Mittendorf J; Drug Discovery, Pharmaceuticals, Bayer AG, Wuppertal D-42096, Germany., Marsault E; Department of Pharmacology-Physiology, Institut de Pharmacologie de Sherbrooke, 3001, 12e av nord, Sherbrooke, Québec J1H 5N4, Canada.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 Jul 09; Vol. 63 (13), pp. 6774-6783. Date of Electronic Publication: 2020 May 26.
Autor:
Grünewald S; Bayer AG, Berlin, Germany., Politz O; Bayer AG, Berlin, Germany., Bender S; Bayer AG, Berlin, Germany., Héroult M; Bayer AG, Berlin, Germany., Lustig K; Bayer AG, Wuppertal, Germany., Thuss U; Bayer AG, Wuppertal, Germany., Kneip C; Bayer AG, Berlin, Germany., Kopitz C; Bayer AG, Berlin, Germany., Zopf D; Bayer AG, Berlin, Germany., Collin MP; Bayer AG, Wuppertal, Germany., Boemer U; Bayer AG, Berlin, Germany., Ince S; Bayer U.S. LLC, Whippany, NJ., Ellinghaus P; Bayer AG, Wuppertal, Germany., Mumberg D; Bayer AG, Berlin, Germany., Hess-Stumpp H; Bayer AG, Berlin, Germany., Ziegelbauer K; Bayer AG, Wuppertal, Germany.
Publikováno v:
International journal of cancer [Int J Cancer] 2019 Sep 01; Vol. 145 (5), pp. 1346-1357. Date of Electronic Publication: 2019 Mar 13.
Autor:
Norden J; Haematological Sciences, Institute of Cellular Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, UK., Pearce KF; Haematological Sciences, Institute of Cellular Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, UK., Irving JAE; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, University of Newcastle upon Tyne, Newcastle upon Tyne, UK., Collin MP; Haematological Sciences, Institute of Cellular Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, UK., Wang XN; Haematological Sciences, Institute of Cellular Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, UK., Wolff D; Department of Haematology and Oncology, University of Regensburg, Regensburg, Germany., Kolb HJ; Klinikum Grosshadern, III Medical Klinik, Munich, Germany., Socie G; Department of Haematology, St Louis Hospital, Paris, France., Kuzmina Z; Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria., Greinix H; Department of Internal Medicine, Division of Haematology, Medical University of Graz, Graz, Austria., Holler E; Department of Haematology and Oncology, University of Regensburg, Regensburg, Germany., Rocha V; EUROCORD, St Louis Hospital, Paris, France., Gluckman E; EUROCORD, St Louis Hospital, Paris, France., Hromadnikova I; Department of Molecular Biology and Cell Pathology, Third faculty of Medicine, Charles University, Prague, Czech Republic., Dickinson AM; Haematological Sciences, Institute of Cellular Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
Publikováno v:
International journal of immunogenetics [Int J Immunogenet] 2018 Jul 25. Date of Electronic Publication: 2018 Jul 25.
Autor:
Collin MP; Department of Medicinal Chemistry, Drug Discovery, Bayer AG, Postfach 101709, 42096, Wuppertal, Germany., Lobell M; Department of Medicinal Chemistry, Drug Discovery, Bayer AG, Postfach 101709, 42096, Wuppertal, Germany., Hübsch W; Department of Medicinal Chemistry, Drug Discovery, Bayer AG, Postfach 101709, 42096, Wuppertal, Germany., Brohm D; Department of Medicinal Chemistry, Drug Discovery, Bayer AG, Postfach 101709, 42096, Wuppertal, Germany., Schirok H; Department of Medicinal Chemistry, Drug Discovery, Bayer AG, Postfach 101709, 42096, Wuppertal, Germany., Jautelat R; Department of Medicinal Chemistry, Drug Discovery, Bayer AG, Postfach 101709, 42096, Wuppertal, Germany., Lustig K; Research Pharmacokinetics Group, Drug Discovery, Bayer AG, Germany., Bömer U; Lead Discovery, Drug Discovery, Bayer AG, Germany., Vöhringer V; Therapeutic Research Group, Oncology, Drug Discovery, Bayer AG, Germany., Héroult M; Therapeutic Research Group, Oncology, Drug Discovery, Bayer AG, Germany., Grünewald S; Therapeutic Research Group, Oncology, Drug Discovery, Bayer AG, Germany., Hess-Stumpp H; Therapeutic Research Group, Oncology, Drug Discovery, Bayer AG, Germany.
Publikováno v:
ChemMedChem [ChemMedChem] 2018 Mar 06; Vol. 13 (5), pp. 437-445. Date of Electronic Publication: 2018 Feb 16.
Autor:
Pearce KF; Haematological Sciences, Institute of Cellular Medicine, William Leech Building, Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK. k.f.pearce@ncl.ac.uk, Lee SJ, Haagenson M, Petersdorf EW, Norden J, Collin MP, Klein JP, Spellman SR, Lowerson SA, Davies S, Dickinson AM
Publikováno v:
Haematologica [Haematologica] 2012 Jul; Vol. 97 (7), pp. 1014-9. Date of Electronic Publication: 2012 Jan 22.
Autor:
Teunissen MB; Department of Dermatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. m.b.teunissen@amc.uva.nl, Haniffa M, Collin MP
Publikováno v:
Current topics in microbiology and immunology [Curr Top Microbiol Immunol] 2012; Vol. 351, pp. 25-76.
Autor:
Benson S; Max-Planck-Institut für Kohlenforschung, 45470 Mülheim an der Ruhr, Germany., Collin MP, Arlt A, Gabor B, Goddard R, Fürstner A
Publikováno v:
Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2011 Sep 05; Vol. 50 (37), pp. 8739-44. Date of Electronic Publication: 2011 Jul 26.